These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 20649938)
1. The EphB4 receptor promotes the growth of melanoma cells expressing the ephrin-B2 ligand. Yang NY; Lopez-Bergami P; Goydos JS; Yip D; Walker AM; Pasquale EB; Ethell IM Pigment Cell Melanoma Res; 2010 Oct; 23(5):684-7. PubMed ID: 20649938 [No Abstract] [Full Text] [Related]
2. Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2-EphB4 Signaling in Melanoma Metastatic Spine Disease. Piffko A; Broggini T; Harms C; Adams RH; Vajkoczy P; Czabanka M Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360793 [TBL] [Abstract][Full Text] [Related]
3. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. Noren NK; Lu M; Freeman AL; Koolpe M; Pasquale EB Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5583-8. PubMed ID: 15067119 [TBL] [Abstract][Full Text] [Related]
5. Ephrin B2/EphB4 mediates the actions of IGF-I signaling in regulating endochondral bone formation. Wang Y; Menendez A; Fong C; ElAlieh HZ; Chang W; Bikle DD J Bone Miner Res; 2014 Aug; 29(8):1900-13. PubMed ID: 24677183 [TBL] [Abstract][Full Text] [Related]
6. Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts. Kwan Tat S; Pelletier JP; Amiable N; Boileau C; Lajeunesse D; Duval N; Martel-Pelletier J Arthritis Rheum; 2008 Dec; 58(12):3820-30. PubMed ID: 19035475 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of Receptor Tyrosine Kinase EphB4 Triggers Tumor Growth and Hypoxia in A375 Melanoma Xenografts: Insights from Multitracer Small Animal Imaging Experiments. Neuber C; Belter B; Meister S; Hofheinz F; Bergmann R; Pietzsch HJ; Pietzsch J Molecules; 2018 Feb; 23(2):. PubMed ID: 29462967 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers. Bhatia S; Sharma J; Bukkapatnam S; Oweida A; Lennon S; Phan A; Milner D; Uyanga N; Jimeno A; Raben D; Somerset H; Heasley L; Karam SD Clin Cancer Res; 2018 Sep; 24(18):4539-4550. PubMed ID: 29848571 [No Abstract] [Full Text] [Related]
9. The protective role of Ephrin-B2/EphB4 signaling in osteogenic differentiation under inflammatory environment. Qu F; Song Y; Wu Y; Huang Y; Zhong Q; Zhang Y; Fan Z; Xu C Exp Cell Res; 2021 Mar; 400(2):112505. PubMed ID: 33516666 [TBL] [Abstract][Full Text] [Related]
10. Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand. Rutkowski R; Mertens-Walker I; Lisle JE; Herington AC; Stephenson SA Int J Cancer; 2012 Sep; 131(5):E614-24. PubMed ID: 22161689 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers. Bhatia S; Oweida A; Lennon S; Darragh LB; Milner D; Phan AV; Mueller AC; Van Court B; Raben D; Serkova NJ; Wang XJ; Jimeno A; Clambey ET; Pasquale EB; Karam SD Cancer Res; 2019 May; 79(10):2722-2735. PubMed ID: 30894369 [TBL] [Abstract][Full Text] [Related]
12. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation. Bai J; Wang YJ; Liu L; Zhao YL J Int Med Res; 2014 Apr; 42(2):405-15. PubMed ID: 24517927 [TBL] [Abstract][Full Text] [Related]
13. EphB4 overexpression in B16 melanoma cells affects arterial-venous patterning in tumor angiogenesis. Huang X; Yamada Y; Kidoya H; Naito H; Nagahama Y; Kong L; Katoh SY; Li WL; Ueno M; Takakura N Cancer Res; 2007 Oct; 67(20):9800-8. PubMed ID: 17942910 [TBL] [Abstract][Full Text] [Related]
14. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development. Cowan CA; Yokoyama N; Saxena A; Chumley MJ; Silvany RE; Baker LA; Srivastava D; Henkemeyer M Dev Biol; 2004 Jul; 271(2):263-71. PubMed ID: 15223333 [TBL] [Abstract][Full Text] [Related]
16. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes. Pfaff D; Héroult M; Riedel M; Reiss Y; Kirmse R; Ludwig T; Korff T; Hecker M; Augustin HG J Cell Sci; 2008 Nov; 121(Pt 22):3842-50. PubMed ID: 18957513 [TBL] [Abstract][Full Text] [Related]
17. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis. Djokovic D; Trindade A; Gigante J; Badenes M; Silva L; Liu R; Li X; Gong M; Krasnoperov V; Gill PS; Duarte A BMC Cancer; 2010 Nov; 10():641. PubMed ID: 21092311 [TBL] [Abstract][Full Text] [Related]
18. Spatiomechanical Modulation of EphB4-Ephrin-B2 Signaling in Neural Stem Cell Differentiation. Dong M; Spelke DP; Lee YK; Chung JK; Yu CH; Schaffer DV; Groves JT Biophys J; 2018 Sep; 115(5):865-873. PubMed ID: 30075851 [TBL] [Abstract][Full Text] [Related]
19. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Wang Y; Nakayama M; Pitulescu ME; Schmidt TS; Bochenek ML; Sakakibara A; Adams S; Davy A; Deutsch U; Lüthi U; Barberis A; Benjamin LE; Mäkinen T; Nobes CD; Adams RH Nature; 2010 May; 465(7297):483-6. PubMed ID: 20445537 [TBL] [Abstract][Full Text] [Related]
20. Generation of transgenic mice overexpressing EfnB2 in endothelial cells. Luxey M; Laussu J; Jungas T; Davy A Genesis; 2011 Oct; 49(10):811-20. PubMed ID: 21735541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]